The Faces of Luminex: Christine Valle, Global Marketing

June 14th, 2019 / Molly Frazier

Here at Luminex, each system we develop has a dedicated team managing every detail of the instruments, reagents, specifications, and more. For our xMAP® Technology, that team is led by Christine Valle, Director of Global Systems & Consumables Marketing. The proud Texas native came to Luminex in 2011 and holds a bachelor’s degree from Sam

Continue reading »

METHODS Special Issue: An Overview of xMAP® Technology

June 11th, 2019 / Hilary Graham

The remarkable history and latest applications of bead-based multiplexing We’re excited that Elsevier’s METHODS journal just released an entire issue dedicated to new areas of innovation related to bead-based biomarker detection. The issue demonstrates the diverse applications of the xMAP® Technology as a research tool and as the platform for clinical diagnostics. The Luminex team

Continue reading »

Reimbursement Advice for Labs Running Molecular Diagnostics

May 15th, 2019 / Molly Frazier

CLP Magazine article offers pro tips and a look at the current landscape If you work with molecular diagnostics, you probably also spend a good amount of time thinking about reimbursement. A new article in the March issue of CLP Magazine from Luminex’s resident reimbursement expert, Stephanie Ibbotson, offers practical advice and education about how

Continue reading »

The Faces of Luminex: Stephanie Ibbotson, Reimbursement

April 26th, 2019 / Molly Frazier

Most people think of Luminex as a tech and assay company, but there’s an essential component that often goes unnoticed: reimbursement. Without having favorable coverage decisions from key payers, clinical labs have a hard time adopting molecular diagnostic products. We rely on Stephanie Ibbotson, Director of Market Access and Reimbursement Affairs, to navigate these challenging

Continue reading »

The Faces of Luminex: Jen Dillman, Product Development

April 11th, 2019 / Molly Frazier

There are a lot of steps between having the idea for a new product and actually making the product for commercial release. Here at Luminex, we count on people like Jen Dillman, Senior Manager of Product Development, to help get new products across the finish line. She joined our Wisconsin-based team in 2009 and earned

Continue reading »

The Faces of Luminex: Heather Darby, LTG Field Applications

March 29th, 2019 / Molly Frazier

The partners who develop new assays based on our xMAP® Technology through Luminex’s Licensed Technologies Group (LTG) are incredibly dedicated and creative — but even they need help with applications development from time to time. That’s where Heather Darby, Field Applications Scientist, comes in. She joined Luminex in 2015 and holds bachelor and master degrees

Continue reading »

Meet Ankit Patel, QuantiGene™ Assay Developer at Thermo Fisher Scientific

March 26th, 2019 / Hilary Graham

Plus: 6 tips for QuantiGene assays When you want an assay that can detect nucleic acids, you’ll likely choose the high-quality Invitrogen™ ProcartaPlex™ and QuantiGene™ Plex assays from Thermo Fisher Scientific, a Luminex partner. The QuantiGene assay uses branched DNA (bDNA) technology, relying on signal amplification instead of target amplification for optimal quantitation of transcripts.

Continue reading »

Querying RAS: How a Multiplex Assay Became a Robust Transcriptional Readout for HTS

March 18th, 2019 / Hilary Graham

In Q&A, scientists describe development and offer multiplexing tips A few years ago, scientists at Merck & Co were looking for a better way to evaluate the activity of the RAS-MAPK pathway, which is particularly important for cancer development and can also signal susceptibility or resistance to emerging therapies. They used the Thermo Fisher QuantiGene™

Continue reading »

The Faces of Luminex: Feng Sun, Bioinformatics

March 15th, 2019 / Molly Frazier

When you get a result from your VERIGENE® assay, what you don’t see is the expertise in bioinformatics and data science that went into designing the assays, setting just the right threshold, analyzing each target for optimal performance, and telling the software how to report the information to you. But you can bet that Feng

Continue reading »

xMAP®-powered Assay Provides Critical Clues from Liquid Biopsy Samples

March 5th, 2019 / Hilary Graham

14-gene assay interrogates circulating tumor cells Liquid biopsies are opening new avenues for cancer research and diagnosis, but even experts in the field continue to nail down the best protocols for analyzing the cell-free DNA and circulating tumor cells (CTCs) contained in these peripheral blood samples. Evi Lianidou, professor of Analytical Chemistry and Clinical Chemistry

Continue reading »